Among the TFs identified here in the response of aggressive CLL lymphocytes, EGR1 and EGR2 are zinc-finger TFs downstream of the Ras/Raf/MAP kinase pathway that is constitutively activated in various cancers and blood malignancies [34]. The gene discussed is EGR1; the disease is B-cell chronic lymphocytic leukemia.